Mundipharma has announced the appointment of Jerome Moreau to the position of head of market access, and will be reporting to Chris Surridge, european director of strategy and commercial excellence.
Jerome joins Mundipharma from GlaxoSmithKline, where he was director of global market access and pricing.
He has over 25 years of experience in biopharma, working in different sales and marketing roles, before progressing into management and business development at leading pharmaceutical companies including Johnson and Johnson.
Chris Surridge commented: “With a proven track record in the market access arena, Jerome has set out clear goals of how he will help to shape, inspire, and enhance our market access capabilities at Mundipharma. We share his view that market access should be closely aligned to business priorities, creating value at every point of the patient journey.
